Beta-Blockers in Asymptomatic Coronary Artery Disease No Benefit or No Evidence?

被引：11
|
作者：
Steg, Philippe Gabriel [1 ,2 ,3 ,4 ]
De Silva, Ranil [4 ,5 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75018 Paris, France
[2] Univ Paris Diderot, Paris, France
[3] INSERM, U 1148, Paris, France
[4] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England
[5] Royal Brompton & Harefield NHS Fdn Trust, NIHR, Cardiovasc Biomed Res Unit, London, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 03期
关键词：
beta-blockers; coronary artery disease; ACUTE MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; CARDIOVASCULAR EVENTS; HEART; CARVEDILOL; METOPROLOL; MORTALITY; THERAPY; OUTPATIENTS; MANAGEMENT;
D O I：
10.1016/j.jacc.2014.04.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [11] β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
    Sorbets, Emmanuel
    Steg, Philippe Gabriel
    Young, Robin
    Danchin, Nicolas
    Greenlaw, Nicola
    Ford, Ian
    Tendera, Michal
    Ferrari, Roberto
    Merkely, Bela
    Parkhomenko, Alexander
    Reid, Christopher
    Tardif, Jean-Claude
    Fox, Kim M.
    EUROPEAN HEART JOURNAL, 2019, 40 (18) : 1399 - +
  • [12] Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease
    Ndrepepa, Gjin
    Braun, Siegmund
    Schoemig, Albert
    Kastrati, Adnan
    CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (04) : 327 - 333
  • [13] Misconceptions and Facts About Beta-Blockers
    Argulian, Edgar
    Bangalore, Sripal
    Messerli, Franz H.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07) : 816 - 819
  • [14] Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40%
    Khalil, Charbel Abi
    Sulaiman, Kadhim
    Asaad, Nidal
    AlHabib, Khalid F.
    Alsheikh-Ali, Alawi
    Jameesh, Mohammed
    Al-Jarallah, Mohammed
    Bulbanat, Bassam
    AlMahmeed, Wael
    Ridha, Mustafa
    Bazargani, Nooshin
    Amin, Haitham
    Al-Motarreb, Ahmed
    AlFaleh, Husam
    Panduranga, Prashanth
    Mahfoud, Ziyad
    Al Suwaidi, Jassim
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (06) : 644 - 651
  • [15] Sexual Dysfunction and the Impact of Beta-Blockers in Young Males With Coronary Artery Disease
    Dai, Yuxiang
    Mei, Zhendong
    Zhang, Shuning
    Shali, Shalaimaiti
    Ren, Daoyuan
    Xu, Lili
    Gao, Wei
    Chang, Shufu
    Zheng, Yan
    Qian, Juying
    Yao, Kang
    Ge, Junbo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [16] Clinical utility of beta-blockers for primary and secondary prevention of coronary artery disease
    Calhoun, McKenzie
    Cross, L. Brian
    Cooper-DeHoff, Rhonda M.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (03) : 289 - 291
  • [17] β-Blockers in coronary artery disease management
    Boudonas, G. E.
    HIPPOKRATIA, 2010, 14 (04) : 231 - 235
  • [18] Beta-Blockers in Acute Coronary Syndrome
    Stoschitzky, Kurt
    CARDIOLOGY, 2010, 115 (03) : 170 - 171
  • [19] The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
    Joseph, Philip
    Swedberg, Karl
    Leong, Darryl P.
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (05) : 672 - 682
  • [20] Is There Evidence Favoring the Use of Beta-Blockers and Dobutamine in Acute Heart Failure?
    Santana Passos, Luiz Carlos
    Costa Barbosa, Andrea Cristina
    Oliveira, Marcio Galvao
    Santos, Edval Gomes, Jr.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (02) : 190 - 197
12345